Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Disorder With Hyperactivity

Explore clinical trials studying Attention Deficit Disorder With Hyperactivity. Study availability and eligibility vary by location and protocol.

164 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Disorder With Hyperactivity trial results

Completed

Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00320528

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Acireale, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Avellino, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bosisio Parini, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy
View all 20 locations
View Trial Details
Completed

The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder

NCT00773916

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ADHD Outpatient Program - Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details
Completed

Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders

NCT00025779

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +14 more
Locations
  • UCLA Neuropsychiatric Institute Los Angeles, California, United States
  • Yale Child Study Center New Haven, Connecticut, United States
  • Indiana University-Riley Hospital for Children Indianapolis, Indiana, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
View Trial Details
Completed

Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children

NCT00031395

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • SUNY Buffalo, Center For Children & Families Buffalo, New York, United States
  • University of Rochester, Department of Neurology Rochester, New York, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study

NCT00595751

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Dothan, Alabama, United States
  • Indian Crest Pediatrics Westminster, Colorado, United States
  • Medical College of Georgia Augusta, Georgia, United States
  • Mercer University School of Medicine Macon, Georgia, United States
View Trial Details
Completed

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

NCT00174226

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site San Diego, California, United States
View Trial Details

Related conditions